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Background: Rye bread benefits glucose metabolism. It is unknown whether the same effect is achieved by rye
bran-enriched wheat bread. We tested whether white wheat bread enriched with bioprocessed rye bran (BRB +WW)
and sourdough wholegrain rye bread (WGR) have similar effects on glucose metabolism and plasma level of short
chain fatty acids (SCFAs).
Methods: Twenty-one (12 women) of 23 recruited subjects completed an intervention with a four-week run-in and
two four-week test periods in cross-over design. White wheat bread (WW; 3% fibre) was consumed during the run-in,
and WGR and BRB +WW (10% fibre) during the test periods. A meal test providing 51/33/11 E % from carbohydrates/
fat/protein was conducted at the end of each period. Fasting and postprandial plasma samples were analysed for
glucose, insulin, and SCFA.
Results: Glucose and insulin responses and plasma concentrations of SCFAs to the meal test were similar between
the WGR and BRB +WW periods. When compared to the WW period, postprandial insulin concentration at 120 min
was lower (p = 0.023) and the first-phase insulin secretion improved (p = 0.033) only after the WGR period, whereas
postprandial concentrations of butyrate (p < 0.05) and propionate (p = 0.009) at 30 min increased during both rye
bread periods.
Conclusions: Beneficial effects of WGR over white wheat bread on glucose and SCFA production were confirmed.
The enrichment of the white wheat bread with bioprocessed rye bran (BRB +WW) yielded similar but not as
pronounced effects than WGR when compared to WW alone. Postprandially measured glucose metabolism and
concentrations of SCFAs provided additional information along with fasting measurements.
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Gastrointestinal symptomsBackground
Potential benefits of rye bread intake over wheat bread
regarding glucose metabolism has been demonstrated
during the past 15 years. A single meal of rye bread has
been repeatedly shown to reduce postprandial insulin re-
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unless otherwise stated.bread [1-3], suggesting a beneficial effect on glucose me-
tabolism. However, the data from longer-term interven-
tions is less clear. Consumption of wholegrain rye bread
enriched with rye bran daily for eight weeks improved
the first-phase insulin secretion measured by the fre-
quently sampled intravenous glucose tolerance test
(FSIGT) in healthy postmenopausal women [4]. Similar
enhancement in the first-phase insulin secretion mea-
sured by the oral glucose tolerance test (OGTT) was
observed in subjects with the features of metabolictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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weeks [5]. In contrast to these findings, no difference
was observed in the first-phase insulin secretion or insu-
lin sensitivity in subjects with metabolic syndrome con-
suming rye bread or a combination of wholegrain wheat
and rye foods daily for 12 weeks, as compared to those
consuming refined wheat foods [6,7].
Reduced glucose responses to a standardized meal test
or OGTT have been observed in second-meal studies
where a single evening meal containing high-fibre barley
kernels was served to healthy subjects ten hours before
the test [8-11]. Furthermore, plasma butyrate and/or
propionate concentrations were found to be increased
after the standardized test breakfast when the preceding
evening meal contained barley when compared with the
evening meal with white wheat bread [8,10,12]. These
data suggest that butyrate and propionate that are pro-
duced by intestinal fermentation of grain fibre after a
meal with whole grain cereals are associated with im-
provement of the later postprandial glucose metabolism.
Regular consumption of high-fibre rye bread could also
affect postprandial glucose metabolism via production of
short chain fatty acids (SCFAs) after a meal test, but to
date, there are no studies to support this.
Wholegrain foods are protective against type 2 dia-
betes and cardiovascular diseases [13], but the protective
factor in wholegrain foods may be assigned to fibre-rich
bran instead of wholegrains per se [14]. In addition to
the beneficial health effects, however, dietary fibre may
cause unwanted gastrointestinal effects such as fla-
tulence, bloating, and abdominal discomfort [15]. In
Finland, rye bread provides 30-50% of the total dietary
fibre intake [16]. Consumption of rye bread has been
shown to cause gastrointestinal symptoms to some but
not to all individuals [17,18]. The majority of fibre in rye
is cell wall polysaccharides – cellulose, arabinoxylan, and
ß-glucan – and fructan (a family of oligo- and polymers
with degree of polymerization 3-60) [19,20]. Fructan is
more readily fermented than cell wall polysaccharides,
and the fructan content of rye might explain the appear-
ance of the gastrointestinal symptoms after rye intake
[21]. Furthermore, the conventional rye bread in Finland
is made of wholegrain flour with sourdough fermenta-
tion, which changes the nutritional quality and health ef-
fects of grain ingredients [22]. Sourdough wholegrain rye
bread has a specific dense structure and sour taste, which
may not appeal to consumers outside the Northern and
Eastern Europe. In other parts of Europe, such as in Italy,
refined grains are regarded as more tasty than whole-
grains, and Italians and English perceive refined grains
healthier than Finns do [23].
To increase the acceptability and to reduce fermenta-
tion-derived differences between wholegrain sourdough
rye bread (WGR) and native rye bran, we baked a whitewheat bread (WW) that was enriched with rye bran bio-
processed with enzymes and yeast (BRB) and contained
the same fibre level as WGR. The aim was to investigate
whether the white wheat bread enriched with bio-
processed rye bran (BRB +WW) promotes similar ef-
fects to WGR on glucose metabolism and plasma levels
of SCFAs in healthy subjects with self-reported gas-
trointestinal symptoms. In addition, we tested whether
responses to consumption of WGR and BRB +WW
differed from that of low-fibre WW.
Methods
Subjects
Healthy men and women were recruited based on one
or several of the following self-reported gastrointestinal
symptoms after ingestion of grain products, especially
rye bread: flatulence, bloating, discomfort, constipation,
and diarrhea. The recruitment of subjects is described in
Figure 1. Exclusion criteria included BMI >35 kg/m2, in-
flammatory bowel disease, celiac disease or the presence
of transglutaminase IgA antibodies (>7 U/ml), type 1 or
2 diabetes, abnormal liver, thyroid, or renal function
(hyper- or hypothyroidism and hypertension controlled
with medication were allowed), fasting serum triglycer-
ides concentration >3.5 mmol/l, fasting serum total
cholesterol concentration >8 mmol/l, alcohol abuse
(>16 portions/week (women)/>24 portions/week (men)),
cereal or milk protein allergy, special diet (such as vege-
tarian or low-carbohydrate diet), and antibiotic use over
the preceding two months. The age, BMI, and fasting
glucose of the subjects ranged from 38 to 65 years, from
19 to 30 kg/m2, and from 4.9 to 6.3 mmol/l, respectively.
When assessed for eligibility, subjects were informed
that participation in the intervention requires daily con-
sumption of bread over three months. Five subjects
mentioned that they had reduced consumption of grain
products due to gastrointestinal symptoms. Other
subjects did not report changes in their habitual
consumption of grain products despite the symptoms.
The subjects provided written informed consent prior
participating in the study. The study was approved
by the Ethics Committee of the Hospital District of
Northern Savo.
Test breads
Refined WW were two commercial breads with 100%
white wheat flour (Vaasan Oy, Finland). For baking the
WGR, wholegrain rye flour was fermented with Baker’s
yeast and lactic acid bacteria (Lb. brevis, Lb. plantarum)
for 22 hours at 30°C. The sourdough was mixed thor-
oughly at the beginning of fermentation but not during
the process. The sourdough was used at the 50% of sub-
stitution level in baking. The bran for the BRB +WW
was fermented with enzymes and yeast and the bread
Figure 1 Flow diagram.
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were left to rest for 20 min in 28°C and 75% relative hu-
midity, mixing twice for two and four minutes during
resting. The breads were prepared in 400 g dough
pieces, proofed for 50 min in 35°C and 80% relative hu-
midity, and baked in 225°C for 20 min, with 15 seconds
steaming in the beginning.
BRB +WW and WGR had the same total fibre content
(10%) and soluble fibre content (2.1%), whereas WW
had lower total fibre content (3%). Furthermore, the
BRB +WW and the WGR contained 0.7% and 1.8% fruc-
tan, 0.4% and 0.7% ß-glucan, and 2.0% and 1.3% soluble
arabinoxylan, respectively. Bioprocessing of the rye bran
and sourdough fermentation of the wholegrain rye flour
reduced the starch content of BRB +WW and WGR by
23% and 32%, respectively. The BRB +WW, WGR, and
WW breads provided 10.3, 7.3, and 9.1% protein, and
3.5, 0.6, and 3.5% fat, respectively.Figure 2 Study design. Test meal included a standardized portion of whi
white wheat bread enriched with bioprocessed rye bran; WGR, wholegrainStudy design
A four-week run-in period with low grain fibre intake
preceded two consecutive four-week test periods with
high grain fibre intake in randomized, cross-over man-
ner (Figure 2). During the run-in period the subjects
were advised to consume 6-10 slices (20-25 g/slice) of
the WW daily. During the test periods, the subjects were
asked to consume 6-10 slices (25-30 g/slice) of the WGR
and BRB +WW daily, in randomized order. The order
of consuming the rye-containing products was random-
ized using the simple randomization method [25]. The
specific amount of bread slices depended on individual
energy requirement of the subjects. The test breads were
provided for the subjects free of charge. The dietician
advised the subjects weekly or biweekly in the practical
management of the diet. Furthermore, the subjects were
advised to maintain their body weight and follow their
habitual living habits throughout the study.te wheat bread, margarine, cheese, cucumber, and juice. BRB +WW,
rye bread; WW, white wheat bread.
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sumption of the test breads, the subjects were required
to exclude other food items possibly causing symptoms
during the whole three-month intervention. Dietary
counseling was based on avoiding vegetables, fruits, and
pulses containing readily fermentable oligo-, di- and
monosaccharides and polyols as well as foods supple-
mented with fructo-oligosaccharide, inulin, or galacto-
oligosaccharide [21]. Instead, the subjects were asked to
favor vegetables, fruits, and berries without or with only
a low content of these fermentable carbohydrates. One
to two small portions of other grain products than the
test breads were allowed daily. If the subject was eating
oatmeal daily during the run-in period, he/she was asked
to keep this habit also during the other periods. If the
subjects experienced constipation during the run-in
period, occasional intake of non-grain fibre supplements
such as dried and soaked plums, linseeds, and sugar beet
fibre were allowed.
Subjects recorded the amount of the test breads and
other grain products using a daily questionnaire, and
filled in four-day food records during the last week of
each period. The food records were analysed for nutrient
intakes using Diet32 software (version 1.4.6.3, Aivo
Finland Oy, Turku, Finland) which includes database
of Finnish foods. Nutrient compositions of the WW,
BRB +WW, and WGR were added to the database.
At screening and after each period, the subjects filled
in a gastrointestinal quality of life questionnaire, GIQLI
[26], which contained 36 questions on the gastrointes-
tinal quality of life. The total score of GIQLI ranges from
0 to 144; the higher the score the better the gastrointes-
tinal quality of life. The subjects also recorded the occur-
rence of specific gastrointestinal symptoms (flatulence,
bloating, rumbling of stomach, abdominal pain, and
heartburn) as well as defecation frequency daily over the
first and last week of each period. The occurrence of
symptoms was assessed by a 5-point scale as follows: 0
no symptoms; 1 slight symptoms; 2 moderate symptoms;
3 severe symptoms; 4 very severe symptoms.
Standardized meal test
Instead of OGTT, we used a standardized meal test for
experimental purpose to study glucose metabolism be-
cause it better reflects real life situation among free liv-
ing individuals. The meal test was performed at the end
of each four-week period. On the day preceding the meal
test, the subjects were asked to avoid unusually large
portions of food and avoid consumption of alcohol for
two days before the meal test. After an overnight fast,
the subjects arrived in the laboratory, their weight was
measured, an intravenous catheter was inserted in the
antecubital vein of the arm and a fasting blood sample
was taken.The meal included white wheat bread (80 g), milk-free
margarine (20 g), cheese (20 g), cucumber (40 g), and
juice concentrate (0.4 dl) diluted in 2.6 dl water. Accord-
ing to manufacturer’s information of each food item, the
meal contained 550 kcal and 3.7 g fibre. Percentage of
energy from carbohydrates, fat and protein was 51%,
33%, and 11%, respectively. Meal eating time was re-
stricted to fifteen minutes. After starting the meal, four
blood samples were taken at 30, 60, 120, and 180
minutes.
Chemical and biochemical analyses
Chemical composition of the test breads regarding pro-
tein, fat, starch, total dietary fibre, soluble fibre and ara-
binoxylan, fructan, and ß-glucan was determined as
described by Nordlund et al [27].
Blood samples were analysed for plasma glucose and
insulin concentrations as follows: glucose was analysed
using Konelab 20XTi Clinical Chemistry Analyser and
Enzymatic photometric (glucose hexokinase) method
(Konelab System Reagents, Thermo Fisher Scientific,
Vantaa, Finland), and insulin was analysed with a chemi-
luminescent immunoassay (Advia Centaur Immunoassay
System, Siemens Medical Solution Diagnostics, Tarrytown,
NY, USA). Concentration of fasting serum total choles-
terol and triglycerides were analysed using commercial
kits (Thermo Electron Corporation, Vantaa, Finland)
and Thermo Fisher Konelab 20XTi Analyser (Thermo
Electron Corporation, Vantaa, Finland). To exclude
celiac disease in screening, fasting serum sample was
analysed by routinely used assay for transglutaminase
IgA antibodies with fluoro-enzyme immunoassay method.
SCFA in 0, 30, and 180 min plasma samples were mea-
sured by gas chromatography as described by Brighenti
[28] with slight modifications using 2-ethyl butyrate
(FLUKA no. 03190; Sigma Aldrich, St. Louis, MO, USA)
as an internal standard instead of iso-valeric acid.
The internal microbiota does not produce 2-ethyl butyr-
ate, and it is consequently not present in biological
samples.
Calculations
Area under the curve (AUC) of glucose and insulin was
calculated for each meal test from the area beneath the
curve above the fasting level from 0 to 120 min using
GraphPad Prism 4.0 for Windows (GraphPad Software,
Inc., San Diego, CA, USA). First-phase insulin secretion,
which is indicative of the insulin secretion capacity with
relation to plasma glucose concentration, was calculated
as following: (insulin 30 min – 0 min)/(glucose 30 min –
0 min). Disposition index (DI), which represents early
insulin secretion taking insulin sensitivity into account,
was calculated as a product of first-phase insulin secre-
tion and insulin sensitivity (ISIcomp; [29]): (insulin 30
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√(G0*I0*GM*IM)) (G0 = fasting glucose concentration;
I0 = fasting insulin concentration; GM =mean of post-
prandial glucose concentrations; IM =mean of post-
prandial insulin concentrations). Since there was no
difference in the occurrence of gastrointestinal symp-
toms between the first and the last week of each period,
the mean of the two weeks was calculated.
Statistical analyses
To make the analysis of data on glucose and insulin re-
sponses at the meal test more similar to that the analysis
of data from 2-hour OGTT, and because there were no
statistically or clinically relevant differences in glucose,
insulin, and SCFA concentrations at 180 min, results for
glucose and insulin responses are reported based on 0,
30, 60, and 120 min plasma samples. The results for
SCFA are reported based on 0 and 30 min plasma sam-
ples. First, glucose, insulin, and SCFA responses were
compared after the WGR and BRB +WW periods. Then,
the WW period was included in the analysis and the
comparisons were made among the three periods. Com-
parisons between and among the periods regarding sub-
jects’ characteristics, intake of nutrients, plasma glucose
and SCFA concentrations, glucose AUC, first-phase in-
sulin secretion, and DI were conducted using General
linear model (GLM) for repeated measures. For GLM,
non-normally distributed variables were logarithmic-
transformed. However, plasma insulin concentrations,
insulin AUC, gastrointestinal symptoms, frequency of
defecation, energy intake, and total fibre intake were not
normally distributed after logarithmic transformation,
and thus were compared among the periods using the
Friedman’s test and between the periods using the Wil-
coxon signed rank test. All analyses were conducted
with SPSS 19.0 for Windows (Chicago, IL). Because of
the experimental purpose of the meal test, p-values for
markers of glucose and insulin metabolism are reported
as non-adjusted values when the comparisons were
made among the three periods. For other variables, the
p-values were corrected for multiple comparisons. P-
values <0.05 were regarded statistically significant. The
data is expressed as mean ± SD or mean ± SEM.
Results
Compliance and tolerance to diet
The subjects consumed the test breads as advised based
on the daily questionnaires. The intake of energy and
percentage of energy from fat did not change during the
intervention, whereas the percentage of energy from
protein was slightly higher during the BRB +WW period
as compared to the other periods (p < 0.05) (Table 1).
The percentage of energy intake from carbohydrates was
lower (p < 0.001) during the BRB +WW period thanduring the other periods due to the lower starch content
of the bread. The intake of total fibre and fibre from the
breads was lower during the WW period than during
the other periods (p < 0.001), and similar between the
BRB +WW and WGR periods. Consumption of other
grain products was similar over each period (1.0 ± 0.6
portions/d). Total serum cholesterol was significantly
(p < 0.01) higher at the end of BRB +WW than WGR
period (Table 2).
At screening, the GIQLI score was 119 ± 12, while at
the end of the run-in, WGR and BRB +WW periods the
score was 127 ± 9, 125 ± 10 and 126 ± 9, respectively.
Thus, the gastrointestinal quality of life of the subjects
was significantly better (p < 0.01) over the 4-week run-in
and test periods than at the screening when they
followed their habitual diet. Based on the questionnaire
on the occurrence of the specific gastrointestinal symp-
toms the subjects reported slight to moderate flatulence
more frequently over the BRB +WW and WGR periods
than over the WW period (p < 0.05). Altogether 24%
(n = 5) and 29% (n = 6) of the subjects reported moder-
ate or severe flatulence over BRB +WW and WGR pe-
riods, respectively, while only one subject reported
moderate or severe flatulence during the WW period.
There were no reported differences in bloating, rumbling
of stomach, abdominal pain, or heartburn among the pe-
riods, and over 90% of the subjects reported none or
slight symptoms. Frequency of defecation was not af-
fected by the period, being on average 1.4 times per day.
Glucose and insulin
Fasting and postprandial glucose and insulin responses
to the meal test did not differ between the WGR and
BRB +WW periods (Figure 3). No difference was found
in glucose and insulin AUCs and the first-phase insulin
secretion (data not shown), and in the disposition index
(DI) (3519 ± 4947 and 3614 ± 2883 for BRB +WW and
WGR periods, respectively) between the periods. How-
ever, response of plasma insulin to the meal test was
lower after the WGR period than after the WW period
at 120 min (p = 0.023, Wilcoxon test) (Figure 3B). On
the other hand, first-phase insulin secretion during the
meal test tended to be higher after the rye bread periods
(p = 0.083, GLM). Also, DI differed among the bread pe-
riods (p = 0.042, GLM), being higher after the WGR
period as compared to the WW period (3614 ± 2883 vs.
2500 ± 1336, p = 0.033, Wilcoxon).
Plasma SCFA
Fasting concentration of total SCFAs (sum of acetate,
propionate, and butyrate mean ± SD of all periods: 89 ±
26 μmol/L) and of individual SCFAs did not differ
among the periods. Acetate concentration accounted for
94% of the total concentration of SCFAs. From fasting to
Table 1 Intake of energy, nutrients, and test breads over the bread periods (n = 21)
WW period BRB +WW period WGR period p-value1
Energy, kJ/d (kcal/d) 8 620 ± 1 720 (2 060 ± 410) 8 410 ± 2 140 (2 010 ± 510) 8 210 ± 1 930 (1 960 ± 460) 0.405
Carbohydrates, E% 43 ± 6 38 ± 7*** 42 ± 7### < 0.001
Protein, E% 20 ± 3 22 ± 3* 20 ± 3# 0.003
Fat, E% 33 ± 5 35 ± 6 32 ± 6 0.094
Total fibre, g/d 21 ± 7 34 ± 10*** 33 ± 10*** < 0.001
Bread, g/d 169 ± 24 195 ± 53 205 ± 50*** < 0.001
Fibre from bread, g/d 5 ± 1 20 ± 5*** 21 ± 5*** < 0.001
1Among the bread periods (GLM for repeated measures adjusted for multiple comparisons; for energy and total fibre Friedman’s test followed by Wilcoxon singed
rank test adjusted for multiple comparisons). Different from WW period: *p < 0.05, ***p < 0.001. Different from BRB +WW period: #p < 0.05, ###p < 0.001. BRB +WW,
white wheat bread enriched with bioprocessed rye bran; E%, percentage of total energy intake; WGR, wholegrain rye bread; WW, white wheat bread. Data are
presented as mean ± SD.
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ate, and butyrate concentrations were similar between
the WGR and BRB +WW periods. However, when com-
parisons were made among all the three periods, propi-
onate concentration tended to differ (p = 0.058, GLM for
time x period interaction) and butyrate concentration
differed significantly (p = 0.011, GLM for time x period
interaction) from fasting to 30 min postprandially
(Figure 4A,B). At 30 min, propionate concentration was
higher after the WGR period than after the WW period
at 30 min (p < 0.01, Wilcoxon test), and butyrate con-
centration was higher after the WGR (p < 0.01, Wilcoxon
test) and BRB +WW periods (p < 0.05, Wilcoxon test)
than after the WW period.
Discussion
In the present study, we compared the effects of four-
week consumption of WGR and BRB +WW on post-
prandial glucose and insulin responses and plasma
concentrations of SCFA after a standardized meal test.
Enrichment of white wheat bread with bioprocessed rye
bran (BRB +WW) produced nearly similar effects than
WGR on glucose metabolism and plasma concentrations
of SCFAs, although the effects of WGR were more pro-
nounced. When compared to the WW bread period,
both rye bread periods increased the release of butyrate
and tended to increase the first phase insulin response,
while reducing the insulin concentration at 120 min
after the test meal. The results suggest that the first-
phase insulin secretion is improved after consuming ryeTable 2 Characteristics of the subjects at end of each bread p
WW period BRB
Weight (kg) 72 ± 14 72 ±
Fasting glucose (mmol/l) 5.1 ± 0.4 5.0
Cholesterol (mmol/l) 5.2 ± 0.9 5.4
Triglycerides (mmol/l) 0.9 ± 0.4 0.9
1Among the bread periods (GLM for repeated measures adjusted for multiple comp
bread enriched with bioprocessed rye bran; WGR, wholegrain rye bread; WW, whitebreads and less insulin is needed in the later postpran-
dial phase to control glucose concentration. Improved
first-phase insulin secretion and subsequent reduced
hyperinsulinemia in later postprandial phase may pre-
vent disturbances in glucose metabolism [30].
BRB +WW included white wheat flour in addition to
rye bran, and had the same fibre content as WGR which
was baked from wholemeal rye flour. The equal fibre
content might explain the similar effects. However, rye
bread given as a single meal may have additional effects
that are independent of the total fibre content of bread.
A single meal of rye bread has been shown to reduce
postprandial insulin response in healthy subjects as com-
pared to that of white wheat bread, and this effect is not
related to the fibre content of the rye bread [2-4]. In the
present study WGR provided 2.5-fold more fructan (3.7
vs. 1.4 g/d) than BRB +WW bread, but inulin-type fruc-
tans do not seem to affect fasting glucose concentration
in humans [31], and there is no evidence that >2 g more
fructan per day would affect insulin metabolism. Sour-
dough fermentation does not seem to play a role in this
effect since also endosperm and wholegrain rye breads
baked without sourdough fermentation process reduce
the acute postprandial insulin response [2]. Furthermore,
a single meal containing BRB +WW bread did not re-
duce the insulin response in our recent postprandial
study [24], indicating that BRB +WW does not have
similar acute effects on glucose metabolism as WGR.
We observed improved first-phase insulin secretion
after consuming WGR as compared to that of WWeriod (n = 21)
+WW period WGR period p-value1
13 72 ± 14 0.133
± 0.5 5.0 ± 0.5 0.449
± 0.9 5.0 ± 0.7## 0.006
± 0.4 1.0 ± 0.6 0.499
arisons). Different from BRB +WW period: ##p < 0.01. BRB +WW, white wheat
wheat bread. Data are presented as mean ± SD.
Figure 3 Fasting and postprandial A) glucose and B) insulin
responses to the meal test following the four-week periods
with consumption of the different test breads (mean ± SEM,
n = 21). *p < 0.05 between the WGR and WW periods (Wilcoxon
signed rank test).▲, BRB +WW, white wheat bread enriched with
bioprocessed rye bran; ●, WGR, wholegrain rye bread; ▀, WW, white
wheat bread.
Figure 4 Fasting and postprandial A) propionate and B)
butyrate concentrations in response to the meal test following
the four-week periods with consumption of the different test
breads (mean ± SEM, n = 21). ▀, after WW period; ▲, after BRB +
WW period; ●, after WGR period. *p < 0.05, **p < 0.01 between the
WGR and WW periods, #p < 0.05 between the BRB +WW and WW
periods (General linear model for repeated measures adjusted for
multiple comparisons). BRB +WW, white wheat bread enriched with
bioprocessed rye bran; WGR, wholegrain rye bread; WW, white
wheat bread.
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subjects was taken into account. To our knowledge we
are the first who have used a standardized meal test to
investigate glucose metabolism after a longer-term regu-
lar intake of rye bread. Some earlier intervention studies
have failed to show effects by rye bread on fasting glu-
cose and insulin concentrations [4,6,32,33] or on specific
parameters of glucose and insulin metabolism measured
by FSIGT [7], as compared to refined wheat bread. How-
ever, consumption of rye bread-based diet has been re-
ported to improve the first-phase insulin secretion in
OGTT as compared to the wheat-based control diet [5],
and an improvement in the first-phase insulin secretion
in OGTT has been observed in subjects with normal
glucose tolerance after consumption of sourdough
wholegrain wheat bread vs. white wheat bread [34].Methodological differences and differences in study pop-
ulations may explain the inconsistencies in these results.
It was postulated that the effects of wholegrains on in-
sulin sensitivity may be mediated by gastrointestinal
hormones secreted postprandially after a meal [7], a con-
dition which is not met in the FSIGT. Unlike FSIGT,
OGTT takes into account the postprandial events, but
in OGTT only glucose is ingested and no digestion is re-
quired. On the contrary, the standardized meal test, as
used in the present study, mimics the true physiological
event of ingestion of a mixture of foods that are digested
to nutrients and absorbed and may differently affect
gastrointestinal hormones.
The increase in fasting cholesterol due to consumption
of the bread containing bioprocessed rye bran may be
explained by slightly, although not statistically signifi-
cant, higher intake of dietary fat during the BRB +WW
period. However, this requires further investigation,
because similar effect was observed in postmenopausal
women consuming a diet containing rye bread enriched
with rye bran and maintaining fat intake unchanged
[35].
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and individual SCFAs in fasting plasma between the rye-
containing and WW diets, supporting the previous find-
ing [36] that consuming high-fibre rye bread does not
seem to affect fasting plasma level of SCFAs in humans.
However, rapid increase in the concentration of plasma
butyrate after the standardized meal was observed fol-
lowing the rye bread periods, while WGR increased also
the concentration of propionate as compared to WW.
Increased butyrate concentrations after rye containing
diets have been observed in human faeces [33,37] and
the portal vein [38,39], and in the peripheral blood of
pigs [36]. We propose that it is possible to observe
the effects of intestinal fermentation on plasma concen-
trations of SCFA in humans when measured in the
postprandial state. The finding that plasma SCFA con-
centration increases rapidly during 30 minutes after the
standardized test meal is similar as detected in previous
studies [8,10,12]. However, the reason for this increase is
currently not known, but most likely the increase re-
flects the metabolism of fibre components from the pre-
vious meals, not from the standardized meal itself.
The improvement in postprandial insulin responses
during the WGR period appeared to occur simultan-
eously with increase in plasma concentrations of propi-
onate and butyrate. This finding is in line with the
second meal studies showing an increase in plasma pro-
pionate and/or butyrate concentrations simultaneously
with reduction in postprandial glucose response after a
standardized breakfast following an evening meal with
barley [8,10,12]. Feeding rye bread to pigs increased
absorption of butyrate from the intestine and lowered
insulin response, suggesting improved insulin sensitivity
either at the liver level or in muscles [39]. Increase in in-
sulin sensitivity has also been associated with increase in
butyrate producing intestinal bacteria in subjects with
metabolic syndrome [40]. However, our study does not
unambiguously support the previously observed associa-
tions between butyrate and glucose metabolism, because
also consumption of the BRB +WW increased plasma
concentration of butyrate at 30 min without significant
improvement in the postprandial insulin responses as
compared to WW. On the other hand, we cannot rule
out that increased concentration of plasma propionate
after consumption of WGR could improve glucose
metabolism.
In our study, self-reported gastrointestinal symptoms
seemed not to limit the consumption of the rye-contain-
ing breads. Surprisingly, subjects’ gastrointestinal quality
of life improved during the controlled consumption of
the test breads. This might be due to avoidance of foods
containing readily fermentable carbohydrates, i.e. certain
vegetables, fruits, pulses, and fibre-supplemented food
products [21]. It is suggested that intake of the rye-containing breads, where most of the fermentable carbo-
hydrates exist as cell wall polysaccharides, is tolerated
better when the total load of the readily fermentable
carbohydrates is reduced. It is noteworthy that the rye-
containing breads did not decrease subjects’ quality of
life despite causing flatulence.
Conclusions
In conclusion, our findings confirm the beneficial effects
of WGR over white wheat bread on glucose and SCFA
production. Also, the enrichment of the white wheat
bread with bioprocessed rye bran yielded similar but not
as pronounced effects than WGR when compared to
WW alone. We hereby present, in a proof of concept
manner, the potential of making healthier alternatives to
white wheat in more widely acceptable and technologic-
ally utilizable form than WGR. Furthermore, the study
emphasizes the importance of postprandial measure-
ments of glucose metabolism and plasma concentrations
of SCFA in addition to fasting measurements.
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